,
Aziz, Zahra
Riddell, Michaela A.
Absetz, Pilvikki
Brand, Margaret
Oldenburg, Brian
Funding for this research was provided by:
American Academy of Family Physicians Foundation
Eli Lily Foundation
Article History
Received: 2 August 2017
Accepted: 2 February 2018
First Online: 17 February 2018
Authors’ information
: Zahra Aziz, MPHis a PhD candidate in the School of Population and Global Health, University of Melbourne in Australia. Her PhD aims to investigates the factors that influence the implementation and transferability of socio-behavioural interventions for the prevention and management of T2DM by identifying the key success factors required to improve their uptake in real-world settings. She has designed the evaluation logic model for PfP-DP and led this implementation evaluation. Before commencing her PhD, she has worked as a researcher and program evaluation specialist in Australia and Pakistan. She has also completed a Master of Public Health degree from the University of Melbourne, Australia.Michaela A Riddell, PhDis an Adjunct Senior Research Fellow at the School of Clinical Sciences at Monash Health. Michaela along with Peers for Progress Investigators designed the Peers for Progress study, conceptualized, managed and supervised collection of data. As the Aust PfP-DP project manager, she contributed to the training of peer leaders and their ongoing support through weekly teleconferences and regular email contact. She assisted in the design of baseline & outcome surveys and process evaluation surveys. She contributed to preliminary data cleaning and submission of data to the Peers for Progress consensus database.Twitter:@micriddell.ORCID ID:Pilvikki Absetz PhDis a Research Director at the University of Eastern Finland, Department of Public Health and Clinical Nutrition, and an Adjunct Professor of Health Promotion at University of Tampere, Faculty of Social Sciences, Finland. She is a behavioural scientist and a global expert in lifestyle interventions in prevention and management of type 2 diabetes and other chronic conditions. She contributed to the planning of the PfP-DP intervention program, and the evaluation framework and measures, as well as to the interpretation of findings and writing of this manuscript.Margaret Brand B.Ec & Acc, MPHMargaret has worked at Monash University for the past 9 years in numerous research roles. She is currently working with the Cancer Research Program at Monash University as the Research Coordinator for the Victorian Lung Cancer Registry (VLCR). In her current position, Margaret is responsible for coordinating data collection from hospital sites within VLCR, including operations, infrastructure, resources and regulatory compliance. In this position, Margaret is responsible for management of data collection staff, management of the VLCR database and producing reports for stakeholders.Brian Oldenburg PhDis Professor and Chair of Non-Communicable Disease Control in the School of Population and Global Health, University of Melbourne, Australia. He is a behavioural scientist and an expert in the prevention and control of chronic conditions. His research program focuses on improving the prevention and control of cardiometabolic conditions such as diabetes, heart disease, and their co-morbidities in Australia and other countries.
: The study received ethics approval from the Monash University Human Research Ethics Committee (MUHREC) Project number CF09/1692 –2009000920. Participants were given a detailed participant information sheet after which written informed consent from all participants was obtained.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.